TATA HEALTH Receives Additional Resumption Guidance from Hong Kong Stock Exchange, Trading Remains Suspended

Deep News
09/08

TATA HEALTH (01255) announced that on September 4, 2025, the company received a letter from the Hong Kong Stock Exchange setting out additional guidance for the resumption of trading of the shares on the Stock Exchange (the "Additional Resumption Guidance", together with the Initial Resumption Guidance, collectively the "Resumption Guidance"):

Re-compliance with Rule 3.10(2) of the Listing Rules.

Additionally, the company's shares continue to be suspended from trading.

免责声明:投资有风险,本文并非投资建议,以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请,作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考,不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证,投资者应自行研究并在投资前寻求专业建议。

热议股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10